Best Practice & Research Clinical Endocrinology & Metabolism

Papers
(The H4-Index of Best Practice & Research Clinical Endocrinology & Metabolism is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
The novel concept of “Onco-Immuno-Endocrinology” led to the discovery of new clinical entity “paraneoplastic autoimmune hypophysitis”111
Editorial Board111
Editorial Board73
Editorial Board72
Recent progress in molecular classification of phaeochromocytoma and paraganglioma60
Genetics of pubertal timing54
Gonadectomy in individuals with a difference of sex development – For whom, when, why, and why not?54
Treatment of acromegaly with the nonpeptide, highly selective somatostatin receptor type 2 agonist paltusotine52
Growth hormone replacement in adults with cured acromegaly: Efficacy and safety50
Menopausal hormone therapy for the management of osteoporosis47
Coronavirus disease 2019 and vitamin D43
Regulation of bone mass: A splendid Orchestra43
Polygenic risk scores for dyslipidemia and atherosclerotic cardiovascular disease: Progress toward clinical implementation42
Editorial Board40
The role of androgens in transgender medicine38
Rare forms of genetic steroidogenic defects affecting the gonads and adrenals38
Sexual health and contraception in the menopause journey38
Prenatal exposure to phthalate esters and its impact on child development37
Immune checkpoint inhibitor-related thyroid dysfunction37
Editorial Board36
Haematological actions of androgens33
Cardiometabolic outcomes of early onset hypogonadism in males32
Optimal surgical approach for digestive neuroendocrine neoplasia primaries: Oncological benefits versus short and long-term complications32
Remnant lipoprotein particles and cardiovascular disease risk31
Molecular basis of symptomatic sporadic primary hyperparathyroidism: New frontiers in pathogenesis30
Acquired disorders of phosphaturia: Beyond tumor-induced osteomalacia29
Non-oestrogen-based and complementary therapies for menopause27
0.06690502166748